Dr. Atul K. Tandon

Founder, NeoBiotechnologies

Bio:
Dr Atul K. Tandon is a cancer and immunology expert with over 40 years’ experience in biomedical research and biotechnology. Known in the life sciences community as “The MAbMan” for his pioneering work on monoclonal antibodies, he played a key role in the early research that led to Herceptin, a breakthrough breast cancer therapy. As the Founder and President of NeoBiotechnologies in the San Francisco Bay Area, Dr Tandon has developed more than 20,000 antibodies used in cancer and disease research worldwide. He regularly shares insights on cancer, immunology, and emerging medical innovations.

Qualifications & Credentials
PhD in Biochemistry/Immunology, 40+ years of experience in the monoclonal antibody industry

LinkedIn:
https://www.linkedin.com/in/atulktandon

Location:
Silicon Valley

Website:
www.neobiotechnologies.com

Media Room:
https://drive.google.com/drive/u/0/folders/10S_6eiC3vzFoo_oFSp3JWw4Gnfcxjh-k

Atul is available for media appearances and opportunities.